{"id":112095,"date":"2023-10-18T13:19:46","date_gmt":"2023-10-18T07:49:46","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=112095"},"modified":"2023-10-18T13:19:51","modified_gmt":"2023-10-18T07:49:51","slug":"glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/","title":{"rendered":"Glenmark introduces a triple-drug combo for type 2 diabetes"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3253902625\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>On Wednesday, <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/GLENMARK\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Glenmark Pharmaceuticals<\/a><\/strong> said it has launched a triple-fixed-dose combination (FDC) drug for the treatment of diabetes.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1162447963\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>Under the name Zita, the compnay has introduced a combination of Teneligliptin, Dapagliflozin and Metformin.&nbsp;<\/p><p>It is indicated to improve glycemic control in patients with Type 2 diabetes.<\/p><p>The company stated that Priced at Rs 14 per tablet (per day), the medication lowers the daily cost of therapy by 30 per cent; making it affordable for the patients.<\/p><div class=\"trade-content_5\" id=\"trade-514310236\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Currently, the compnay shares are trading 0.75% up at Rs. 807.65.<\/p><p>The drug helps improve glycemic control among adult patients with high HbA1c and other co-morbidities; while also reducing major renal and cardiac adverse events. Glenmark Pharma President &amp; Business Head (India Formulations) Alok Malik said.<\/p><p>According to IQVIA sales data for the 12-month period ending August 2023, the market for oral anti-diabetic drugs in India is estimated at Rs 12,522 crore, with an annual growth of 6.5 per cent against the corresponding period last year.<\/p><p>Glenmark Pharmaceuticals Ltd the company manufactures speciality and generic drugs. Its product category includes novel molecular entities, formulations, and API products.<\/p><div class=\"trade-after-content\" id=\"trade-4032100837\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>On Wednesday, Glenmark Pharmaceuticals said it has launched a triple-fixed-dose combination (FDC) drug for the treatment of diabetes. Under the name Zita, the compnay has introduced a combination of Teneligliptin, Dapagliflozin and Metformin.&nbsp; It is indicated to improve glycemic control in patients with Type 2 diabetes. The company stated that Priced at Rs 14 per [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":106029,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1696,31],"tags":[],"class_list":["post-112095","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate-action","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Glenmark introduces a triple-drug combo for type 2 diabetes - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"On Wednesday, Glenmark Pharmaceuticals said it has launched a triple-fixed-dose combination (FDC) drug for the treatment of diabetes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glenmark introduces a triple-drug combo for type 2 diabetes\" \/>\n<meta property=\"og:description\" content=\"On Wednesday, Glenmark Pharmaceuticals said it has launched a triple-fixed-dose combination (FDC) drug for the treatment of diabetes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-18T07:49:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-18T07:49:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/\",\"url\":\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/\",\"name\":\"Glenmark introduces a triple-drug combo for type 2 diabetes - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg\",\"datePublished\":\"2023-10-18T07:49:46+00:00\",\"dateModified\":\"2023-10-18T07:49:51+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"On Wednesday, Glenmark Pharmaceuticals said it has launched a triple-fixed-dose combination (FDC) drug for the treatment of diabetes.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glenmark introduces a triple-drug combo for type 2 diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Glenmark introduces a triple-drug combo for type 2 diabetes - Trade Brains Features","description":"On Wednesday, Glenmark Pharmaceuticals said it has launched a triple-fixed-dose combination (FDC) drug for the treatment of diabetes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/","og_locale":"en_US","og_type":"article","og_title":"Glenmark introduces a triple-drug combo for type 2 diabetes","og_description":"On Wednesday, Glenmark Pharmaceuticals said it has launched a triple-fixed-dose combination (FDC) drug for the treatment of diabetes.","og_url":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-10-18T07:49:46+00:00","article_modified_time":"2023-10-18T07:49:51+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/","url":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/","name":"Glenmark introduces a triple-drug combo for type 2 diabetes - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg","datePublished":"2023-10-18T07:49:46+00:00","dateModified":"2023-10-18T07:49:51+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"On Wednesday, Glenmark Pharmaceuticals said it has launched a triple-fixed-dose combination (FDC) drug for the treatment of diabetes.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/glenmark-introduces-a-triple-drug-combo-for-type-2-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Glenmark introduces a triple-drug combo for type 2 diabetes"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/112095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=112095"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/112095\/revisions"}],"predecessor-version":[{"id":112135,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/112095\/revisions\/112135"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/106029"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=112095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=112095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=112095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}